A Case Series of 13 Patients with COVID-19 Associated Respiratory Symptoms Treated with Nebulized OTR4120 (Cacipliq20®). acmcr. 2022;6(4):604-610. Accessed September 11, 2026. https://fortunejournals.org/ojs/index.php/acmcr/article/view/22658